Pages that link to "Q44461407"

The following pages link to Efficacy and safety of timolol maleate/latanoprost fixed combination versus timolol maleate and brimonidine given twice daily (Q44461407):

Displaying 18 items.

• The management of glaucoma and intraocular hypertension: current approaches and recent advances (Q22305849) (← links)
• Clinical utility and differential effects of prostaglandin analogs in the management of raised intraocular pressure and ocular hypertension (Q34043309) (← links)
• Fixed combination of topical brimonidine 0.2% and timolol 0.5% for glaucoma and uncontrolled intraocular pressure (Q34996623) (← links)
• Brimonidine purite 0.15% versus dorzolamide 2% each given twice daily to reduce intraocular pressure in subjects with open angle glaucoma or ocular hypertension (Q35592196) (← links)
• Short term efficacy and safety in glaucoma patients changed to the latanoprost 0.005%/timolol maleate 0.5% fixed combination from monotherapies and adjunctive therapies (Q35592524) (← links)
• An evaluation of the fixed-combination of latanoprost and timolol for use in open-angle glaucoma and ocular hypertension (Q35753429) (← links)
• Meta-analysis of randomised controlled trials comparing latanoprost with brimonidine in the treatment of open-angle glaucoma, ocular hypertension or normal-tension glaucoma. (Q35762849) (← links)
• Predictive value of the efficacy of glaucoma medications in regulatory trials: Phase I-III to post-marketing studies (Q36856440) (← links)
• Pharmacological management of primary open-angle glaucoma: second-line options and beyond (Q37253030) (← links)
• Latanoprost/timolol fixed combination for the treatment of glaucoma. (Q38117401) (← links)
• Administration of the fixed combination of latanoprost 0.005% and timolol 0.5% in glaucoma patients with an intraocular pressure over 30 mmHg (Q41939266) (← links)
• Reporting of noninferiority and equivalence randomized trials for major prostaglandins: a systematic survey of the ophthalmology literature (Q42029736) (← links)
• Efficacy and safety of the latanoprost/timolol maleate fixed combination vs concomitant brimonidine and latanoprost therapy (Q44810299) (← links)
• Brimonidine 0.2% vs unoprostone 0.15% both added to timolol maleate 0.5% given twice daily to patients with primary open-angle glaucoma or ocular hypertension (Q44849772) (← links)
• Daytime diurnal curve comparison between the fixed combinations of latanoprost 0.005%/timolol maleate 0.5% and dorzolamide 2%/timolol maleate 0.5%. (Q44952434) (← links)
• Dorzolamide/timolol fixed combination versus latanoprost/timolol fixed combination in patients with primary open-angle glaucoma or ocular hypertension (Q46739178) (← links)
• Effects of topical antiglaucoma medications on the ocular surface (Q79387442) (← links)
• Twenty-four-hour Intraocular Pressure Control With Latanoprost-timolol-fixed Combination Versus Bimatoprost in Patients Who Switched From Timolol (Q82297989) (← links)